BioScience Health Innovations (BHIC) Cash from Financing Activities (2019 - 2026)
BioScience Health Innovations has reported Cash from Financing Activities over the past 8 years, most recently at $1.0 million for Q1 2026.
- Quarterly Cash from Financing Activities rose 1433.25% to $1.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $851751.0 through Mar 2026, up 43.9% year-over-year, with the annual reading at -$115920.0 for FY2025, 117.94% down from the prior year.
- Cash from Financing Activities was $1.0 million for Q1 2026 at BioScience Health Innovations, up from -$366016.0 in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $1.0 million in Q1 2026 and troughed at -$366016.0 in Q4 2025.
- The 5-year median for Cash from Financing Activities is $74782.5 (2023), against an average of $137207.6.
- Year-over-year, Cash from Financing Activities crashed 191.82% in 2025 and then soared 1433.25% in 2026.
- A 5-year view of Cash from Financing Activities shows it stood at $40000.0 in 2022, then decreased by 15.73% to $33707.0 in 2023, then surged by 1082.55% to $398602.0 in 2024, then crashed by 191.82% to -$366016.0 in 2025, then skyrocketed by 382.83% to $1.0 million in 2026.
- Per Business Quant, the three most recent readings for BHIC's Cash from Financing Activities are $1.0 million (Q1 2026), -$366016.0 (Q4 2025), and $180461.0 (Q3 2025).